Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9945 - 9952 of 12011 results
President Obama Announces Executive Action on Immigration
November 21, 2014| Alert| Viewpoint
The difference a day can make: States devise their own remedies for criminal immigration reform
November 21, 2014| Blog| Viewpoint
Hot Bench from the Ninth Circuit Hears Appeal from Ruling Blocking Hospital–Physician Group Merger
November 21, 2014| Alert| Viewpoint
Class Action Defense Counsel adding ‘The Pick Off’ to Their Playbooks
November 21, 2014| Blog| Viewpoint
Cloture Filed on Adler Nomination; Burgess Named Subcommittee Chairman
November 21, 2014| Blog| Viewpoint
Federal Court Holds That Lack of Loss Causation Is Not a Defense Under Massachusetts Blue Sky Law
November 20, 2014| Blog| Viewpoint
Strategies for Efficiently Obtaining Antitrust Clearance
November 20, 2014| Blog| Viewpoint
Vascular Solutions Inc. and its CEO Face Criminal Charges for Selling Unapproved Medical Devices
November 20, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|